Date | Price Target | Rating | Analyst |
---|---|---|---|
6/26/2024 | $2.00 | Neutral | Piper Sandler |
12/13/2022 | $3.00 → $2.00 | Buy → Neutral | Citigroup |
7/12/2022 | $6.50 | Neutral | Goldman |
12/20/2021 | $9.00 → $7.00 | Buy | Citigroup |
11/11/2021 | $7.00 → $6.00 | Equal-Weight | Barclays |
10/4/2021 | $9.00 | Buy | Citigroup |
8/20/2021 | $9.00 | Buy | Tigress Financial |
SC 13G/A - MultiPlan Corp (0001793229) (Subject)
SC 13G/A - MultiPlan Corp (0001793229) (Subject)
SC 13G/A - MultiPlan Corp (0001793229) (Subject)
Piper Sandler analyst Jessica Tassan initiates coverage on MultiPlan (NYSE:MPLN) with a Neutral rating and announces Price Target of $2.
Gainers Anitra (AMEX:AZTR) shares increased by 6.5% to $0.18 during Wednesday's after-market session. The market value of their outstanding shares is at $5.1 million. Oragenics (AMEX:OGEN) shares increased by 4.24% to $2.04. The market value of their outstanding shares is at $9.1 million. PACS Group (NYSE:PACS) shares rose 3.95% to $31.52. The market value of their outstanding shares is at $4.8 billion. MultiPlan (NYSE:MPLN) shares moved upwards by 3.49% to $0.45. The market value of their outstanding shares is at $290.3 million. Nanoviricides (AMEX:NNVC) stock moved upwards by 2.01% to $2.48. The market value of their outstanding shares is at $29.2 million. Calidi Biotherapeutics (AME
Piper Sandler initiated coverage of MultiPlan with a rating of Neutral and set a new price target of $2.00
Citigroup downgraded MultiPlan from Buy to Neutral and set a new price target of $2.00 from $3.00 previously
Goldman initiated coverage of MultiPlan with a rating of Neutral and set a new price target of $6.50
Employees commended the company's inclusive, supportive, and diverse workplace culture MultiPlan Corporation (NYSE:MPLN) ("MultiPlan" or the "Company"), a leading provider of technology and data-enabled cost management, payment, and revenue integrity solutions to the U.S. healthcare industry, is proud to announce it has been Certified™ by Great Place to Work® for the third consecutive year. In surveying current employees this year about their experience working at MultiPlan, 87% said it's a great place to work – far above the 57% overall satisfaction of employees at a typical U.S.-based company. Great Place To Work® is the global authority on workplace culture, employee experience, and
As required by the rules of the New York Stock Exchange, MultiPlan Corporation (NYSE:MPLN) ("MultiPlan" or the "Company") today announced that it has granted to Douglas Garis, the Company's recently appointed Executive Vice President, Chief Financial Officer and Treasurer, on August 5, 2024, employment inducement awards consisting of the following: (i) 4,901,960 stock options with such options vesting over a three-year period from August 5, 2024, in substantially equal annual installments, subject to Mr. Garis' continued employment; and (ii) 3,571,428 restricted stock units with such units vesting over a three-year period from August 5, 2025, in substantially equal annual installments, subj
– Q2 2024 Revenues of $233.5 million, Net Loss of $576.7 million (including a $553.7 million impairment of goodwill), and Adjusted EBITDA of $146.7 million – Identified potential medical cost savings of approximately $6.2 billion in Q2 2024, up 9% from Q2 2023 and up 8% from Q1 2024 – CFO transition plan announced MultiPlan Corporation ("MultiPlan" or the "Company") (NYSE:MPLN), a leading value-added provider of data analytics and technology-enabled end-to-end cost management, payment and revenue integrity solutions to the U.S. healthcare industry, today reported financial results for the second quarter ended June 30, 2024 and updated its full-year 2024 guidance. CEO Travis Dalton s
– Q2 2024 Revenues of $233.5 million, Net Loss of $576.7 million (including a $553.7 million impairment of goodwill), and Adjusted EBITDA of $146.7 million – Identified potential medical cost savings of approximately $6.2 billion in Q2 2024, up 9% from Q2 2023 and up 8% from Q1 2024 – CFO transition plan announced MultiPlan Corporation ("MultiPlan" or the "Company") (NYSE:MPLN), a leading value-added provider of data analytics and technology-enabled end-to-end cost management, payment and revenue integrity solutions to the U.S. healthcare industry, today reported financial results for the second quarter ended June 30, 2024 and updated its full-year 2024 guidance. CEO Travis Dalton s
MultiPlan Corporation ("MultiPlan" or the "Company") (NYSE:MPLN), a leading value-added provider of data analytics and technology-enabled end-to-end cost management, as well as payment and revenue integrity solutions to the U.S. healthcare industry, announced today that it will release its second quarter 2024 financial results on Thursday, August 1, 2024, and hold its conference call that morning at 9:30 am Eastern Time. To join the conference call, please pre-register using the following link at least 10 minutes before the call begins: https://www.netroadshow.com/events/login?show=f096f8c3&confId=66913. Upon registration, you will receive an email with the conference dial-in details and
– Q1 2024 Revenues of $234.5 million, Net Loss of $539.7 million (including a $519.1 million impairment of goodwill and indefinite-lived intangible assets), and Adjusted EBITDA of $146.8 million – Identified potential medical cost savings of approximately $5.7 billion in Q1 2024, up 3% from Q1 2023 and down 3% from Q4 2023 – Repurchased or repaid $24.4 million of face value of debt, including $21.1 million of 6.0% Senior Convertible PIK Notes MultiPlan Corporation ("MultiPlan" or the "Company") (NYSE:MPLN), a leading value-added provider of data analytics and technology-enabled end-to-end cost management, payment and revenue integrity solutions to the U.S. healthcare industry, today r
4 - MultiPlan Corp (0001793229) (Issuer)
4 - MultiPlan Corp (0001793229) (Issuer)
4 - MultiPlan Corp (0001793229) (Issuer)
4 - MultiPlan Corp (0001793229) (Issuer)
4 - MultiPlan Corp (0001793229) (Issuer)
4 - MultiPlan Corp (0001793229) (Issuer)
MultiPlan Corporation ("MultiPlan" or the "Company") (NYSE:MPLN), a leading value-added provider of data analytics and technology-enabled end-to-end cost management, as well as payment and revenue integrity solutions to the U.S. healthcare industry, announced today its CFO transition plan and named Doug Garis as EVP and CFO, effective August 5, 2024. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240731993142/en/Doug Garis named EVP and CFO of MultiPlan (Photo: Business Wire) Jim Head, who has served as EVP and CFO of MultiPlan since November 2021, will transition to a Strategic Advisor role to the Company through the end of the
MultiPlan Corporation (NYSE:MPLN) ("MultiPlan" or the "Company"), a leading value-added provider of data analytics and technology-enabled end-to-end cost management, as well as payment and revenue integrity solutions, to the U.S. healthcare industry, today announced that Great Place To Work® and Fortune magazine have recognized the Company as one of the Best Workplaces in New York™ for 2024. This marks the second consecutive year MultiPlan has been named to this prestigious list. "Our inclusion on this list makes clear the unwavering investment we make in our employees' long-term success," said Carol Nutter, SVP and Chief People Officer at MultiPlan. "MultiPlan prides itself on maintainin
Hogge's Growth-Driven Expertise Bolsters MultiPlan's Next Phase of Growth and Innovation MultiPlan Corporation (NYSE:MPLN) ("MultiPlan" or the "Company"), a leading value-added provider of data analytics and technology-enabled end-to-end cost management, as well as payment and revenue integrity solutions to the U.S. healthcare industry, today announced that Jerry Hogge will join the Company as Executive Vice President, Chief Operating Officer (COO). Hogge is a highly accomplished operational and commercial leader who has excelled within the healthcare and telecommunications industries for over 30 years. He has a wide range of experience driving operational efficiency and growth in compl
S-8 - MultiPlan Corp (0001793229) (Filer)
S-8 POS - MultiPlan Corp (0001793229) (Filer)
10-Q - MultiPlan Corp (0001793229) (Filer)